Metformin for the prevention of diabetes among people with HIV and either impaired fasting glucose or impaired glucose tolerance (prediabetes) in Tanzania: a Phase II randomised placebo-controlled trial

AIMS/HYPOTHESIS: In sub-Saharan Africa (SSA), 5% of adults are living with type 2 diabetes and this is rising sharply, with a greater increase among people with HIV. Evidence on the efficacy of prevention strategies in this cohort is scarce. We conducted a Phase II double-blind placebo-controlled tr...

Descripción completa

Detalles Bibliográficos
Autores principales: Garrib, Anupam, Kivuyo, Sokoine, Bates, Katie, Ramaiya, Kaushik, Wang, Duolao, Majaliwa, Edna, Simbauranga, Rehema, Charles, Godbless, van Widenfelt, Erik, Luo, Huanyan, Alam, Uazman, Nyirenda, Moffat J., Jaffar, Shabbar, Mfinanga, Sayoki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10474205/
https://www.ncbi.nlm.nih.gov/pubmed/37460828
http://dx.doi.org/10.1007/s00125-023-05968-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10474205/
https://www.ncbi.nlm.nih.gov/pubmed/37460828
http://dx.doi.org/10.1007/s00125-023-05968-7

Ejemplares similares